Medication

The ancient wisdom of "mens sana in corpore sano" reminds us that mental and physical health are inseparable. Reimagining healthcare to bridge this divide will prevent unnecessary interventions, save lives, and foster well-being.

Dysthymia, or dysthymic disorder, is a constant, low-grade depression that often goes under the radar. But according to Dr. Beth Salcedo, Medical Director of The Ross Center and former ADAA Board president, it doesn’t have to be a way of life. It is diagnosable and treatable.

Telehealth allows for increased access to care, providing a flexible option for families, and allows for exposure work in the home setting where compulsions may be the strongest. Yet, telehealth does not come without challenges.

As a medication used traditionally as an anesthetic, ketamine now shines as a potential lifeline for those battling severe depression, anxiety, and suicidality. Its ability to provide rapid and effective relief in treatment-resistant cases offers hope to those struggling with severe mental health challenges.

Experts Mona Potter, MD and Kathryn Boger, PhD, ABPP recently partnered with ADAA to host an insightful Q&A webinar addressing strategies for parenting children with anxiety and OCD. This blog to addresses the most common themes that emerged from the questions asked during the webinar.

Although primary care physicians and other non-specialists in mental health feel comfortable managing less complicated anxiety-related disorders, OCD is a more complex diagnosis and ideally should be managed by a psychiatrist.  Before initiating medication, the psychiatrist will first do a thorough assessment to ensure that the diagnosis of OCD is accurate, and to determine the presence of coexisting conditions that may complicate the treatment.

In collaboration with The Reach Institute, Dr. Wallace explains how parents can decrease the impact of anxiety on children and teens to help them function their best and find more joy in their lives.

Please note that this is an opinion piece by an ADAA colleague member --    "...the conclusion of a study published in Molecular Psychiatry in July 2022 – that there is “no support for the hypothesis that depression is caused by lowered serotonin activity or concentrations” – is not surprising, or even new. What is surprising is that popular media is interpreting the study’s conclusions to say that if serotonin is not the cause of depression, then antidepressants don’t work. Huh?   

Nutraceuticals and herbal remedies are very popular in the United States and worldwide.  Reasons for their popularity include access without a prescription, and generally fewer side effects compared to prescription drugs.  However, the safety and efficacy products are less well studied and understood compared to FDA approved drugs. With growing use, we have seen more cases of serious side effects, toxic reactions, and interactions with other drugs.  Shopping for nutraceuticals can also be tricky because different commercial preparations may vary in purity and strength.  Finally, these treatments are not generally covered by medical insurance, so the consumer must pay out of pocket.